Bright Minds Biosciences (DRUG) Change in Accured Expenses: 2020-2021

Historic Change in Accured Expenses for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to $258,511.

  • Bright Minds Biosciences' Change in Accured Expenses rose 128.25% to $258,511 in Q3 2021 from the same period last year, while for Sep 2021 it was $784,093, marking a year-over-year change of. This contributed to the annual value of $330,326 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2021, Bright Minds Biosciences' Change in Accured Expenses is $258,511, which was down 19.93% from $322,860 recorded in Q2 2021.
  • In the past 5 years, Bright Minds Biosciences' Change in Accured Expenses ranged from a high of $322,860 in Q2 2021 and a low of $25,915 during Q4 2020.
  • For the 2-year period, Bright Minds Biosciences' Change in Accured Expenses averaged around $179,470, with its median value being $176,807 (2021).
  • Data for Bright Minds Biosciences' Change in Accured Expenses shows a peak YoY surged of 128.25% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Bright Minds Biosciences' Change in Accured Expenses stood at $25,915 in 2020, then spiked by 128.25% to $258,511 in 2021.
  • Its last three reported values are $258,511 in Q3 2021, $322,860 for Q2 2021, and $176,807 during Q1 2021.